TrialPath
Recruiting

Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases

NCT07531732 · Assistance Publique - Hôpitaux de Paris
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Study of the Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases in People With Frontotemporal Lobar Degeneration, Behavioral Variant and Alzheimer's Disease
About this study
Self-awareness impairments are common in neurodegenerative diseases, yet their relationship with social cognition remains poorly understood. This study aims to characterize metacognitive processes associated with social cognition in bvFTD and AD, and to determine whether these processes differ across diagnostic groups. The primary objective is to evaluate metacognitive efficiency during a facial emotion recognition task using trial-by-trial retrospective confidence judgments, allowing computation of Mratio. This index reflects the alignment between perceived and actual performance. Secondary objectives include: (1) assessing additional metacognitive measures (prospective and global judgments), (2) comparing metacognition between bvFTD and AD, (3) examining correlations between metacognitive judgments and social cognitive performance, (4) testing domain specificity by comparing social cognition and memory, (5) evaluating the effect of task complexity, (6) assessing the impact of performance feedback, (7) comparing subjective versus objective metacognitive assessments, (8) investigating the role of anosognosia in AD, and (9) exploring associations with hypnotic suggestibility. Participants will attend two visits (\~2 hours each). The first visit includes eligibility assessment, sociodemographic data collection, and a computerized emotion recognition task with metacognitive judgments. The second visit includes additional computerized tasks assessing theory of mind and memory, and an optional hypnotic suggestibility assessment. Statistical analyses will include between-group comparisons using non-parametric tests, within-subject analyses, and exploratory correlational and regression analyses.
Eligibility criteria
Inclusion Criteria: * Diagnosis of possible or probable behavioral variant frontotemporal dementia according to the Rascovsky 2011 criteria (DLFTvc group) OR * Diagnosis of Alzheimer's disease according to the Jack 2018 criteria, including biomarkers (MA group) * Mini-Mental State Examination (MMSE) ≥ 20 * Age: 50-80 years * Sufficient reading and writing proficiency in French to enable completion of the study procedures, in the investigator's opinion Exclusion Criteria: * Moderate to severe language disorders: Confrontation naming (DO 40 scale) ≤ 32 * Inability to perform computerized tasks according to the investigator's opinion * Other neurological disorders (including epilepsy, Lewy body disease, vascular dementia) * Psychiatric comorbidities (bipolar disorder, schizophrenia, current major depressive episode) * Uncorrected visual impairment
Study design
Enrollment target: 34 participants
Age groups: adult, older_adult
Timeline
Starts: 2026-04
Estimated completion: 2027-12
Last updated: 2026-04-15
Interventions
Behavioral: Computer-based facial expression recognition taskBehavioral: Computerized affective taskBehavioral: UCLA Structured Insight InterviewBehavioral: Barber's Standardized Suggestibility Scale
Primary outcomes
  • Metacognitive efficiency during facial emotion recognition (Mratio) (Day 0)
Sponsor
Assistance Publique - Hôpitaux de Paris · other
With: Institut de psychologie, Université Paris Cité, Laboratoire Mémoire, Cerveau, Cognition
Contacts & investigators
ContactEmmanuel Cognat, MD PhD · contact · emmanuel.cognat@aphp.fr · +33 (0) 1 40 05 49 54
All locations (1)
Cognitive Neurology Center, Lariboisière-Fernand Widal Hospital Group, APHPRecruiting
Paris, France
Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases · TrialPath